IIP Recognition for Substance Abuse Testing Lab Trimega Laboratories

LONDON, Nov. 11, 2010 /PRNewswire/ -- UK based Trimega Laboratories is pleased to announce that it has been recognized as having met the standards set by the prestigious Investors in People (IIP) Standard.

Its accreditation follows an examination by the Employer Representative Quality Board of IIP and reflects the commitment and hard work undertaken by Trimega Laboratories as an organization. A significant aspect of the achievement is that, as a substance abuse testing company serving a global market, its 40 strong workforce is spread across offices and laboratories many different locations – including Germany and South Africa.

Douglas MacSween, General Manager of Trimega Laboratories, commented: "This credential shows that we, as a company, are committed to the development of our staff in all aspects and are raising the bar in our sector. A key ingredient of our exceptional team is a thorough understanding of our market needs that enables us to focus on the delivery of quality service whilst meeting tight court deadlines. Because we are always mindful that a drug and alcohol test is not just a scientific result but a process that puts children into safer environments, we are all prepared to go the extra mile."

Trimega Laboratories is one of a very small number of specialist companies in the UK that test hair samples for evidence of alcohol or drug abuse. The vast majority of circumstances in which people are required to undergo a hair strand test in the UK are when a child care application is made to a Family Court by one of the UK's Local Authorities.

More information about hair strand testing is available at: http://www.trimegalabs.com.

About Trimega Laboratories: Established in London in 2005, Trimega Laboratories (http://www.trimegalabs.com) has developed a range of innovative techniques for testing substances of abuse. Its core business is laboratory-based analysis of hair samples that provides accurate historical records of any alcohol or drugs dependency over a one to 12 month period.

SOURCE Trimega Laboratories

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED